ArticleTheranostics2025

Association of integrated biomarkers and progression-free survival prediction in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy.

Felix L Herr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.